DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Non Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China
Lu · Shun_lu@hotmail.com · 021-22200000

Study leads

Lu
Principal Investigator
Shanghai Chest Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non Squamous Non Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Anam, South Korea · Anyang, South Korea

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · NSCLC (Non-small Cell Lung Cancer)

Abroad (travel likely)RecruitingPHASE1

Orlando, United States · Boston, United States

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

NSCLC · NSCLC, Stage I · NSCLC Stage II

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States

A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Advanced Solid Tumors · Breast Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hefei, China · Fuzhou, China